Napo Pharmaceuticals

Digestive Health Day
#Digestive health #Gastrointestinal #Napo Pharmaceuticals #Plant-based

Plant-based drug reduces symptoms in functional diarrhoea patients

This World Digestive Health Day, Napo Pharmaceuticals has announced positive results of a third-party, investigator-initiated study of crofelemer, Napo’s novel plant-based prescription drug. The study results show that twice daily oral administration of crofelemer led to a statistically meaningful reduction of abdominal pain and discomfort and… Read More

#News #Trending News

Stomach pain
#Cancer treatment #Chemotherapy #Napo Pharmaceuticals #Oncology #Preclinical investigations #Puma Biotechnology

Prescription drug could prevent cancer therapy-related diarrhoea

A study in dogs has shown that crofelemer can provide symptomatic relief of diarrhoea associated with the irreversible pan-human epidermal growth factor receptor (HER) tyrosine kinase inhibitor (TKI) neratinib (Nerlynx). Puma Biotechnology’s Nerlynx is a pan HER TKI indicated for the extended adjuvant treatment of adult… Read More

#Cancer Research #News